Skip to main content
Caplight Logo









MultiplexDX

MultiplexDX

Private
BratislavaHealthcare & Life Scienceshttps://www.multiplexdx.com/

Last Round

Grant

Mar 7, 2025

Total Funding Raised

$4.82M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MultiplexDX is a biotechnology company that manufactures diagnostics kits and provides services intended to eliminate cancer misdiagnosis. The company's services combine molecular biology and histopathological methods for the treatment of tumors and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

molecular diagnosticscancer diagnosticsbreast cancer diagnosticsRNA sequencingRNA-seqRNA FISHspatial biologyprecision oncologycompanion diagnosticsprognostic testgene expression analysisbioinformatics servicesin vitro diagnosticsIVDcustom oligonucleotidesRT-qPCR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MultiplexDX Comparables

Compare MultiplexDX with similar companies based on industry and business-model similarity.

MultiplexDX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Veracyte
78%
Agendia
76%
Rna Diagnostics Inc.
76%

MultiplexDX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 7, 2025
VC RoundJun 27, 2023
GrantDec 12, 2019
SeedSep 1, 2018
GrantJul 1, 2018
Seed
May 16, 2016

Key People

Founding team and executive leadership

Pavol Cekan

Founder CEO

Founding Team

Petra Lipnicka

Chief Operating Officer

Executive Team

MultiplexDX Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased from 0 to 12, representing 27% of headcount.

  • Aug 24, 2025

    Grew 15% QoQ, from 39 to 45 employees.

MultiplexDX Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MultiplexDX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MultiplexDX's valuation, stock price, and market status.

Firmographic Details

HeadquartersBratislava
Employee Range44
Year Founded2015
Last FundingMar 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?